Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better ...

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

A scan revealed that an Egyptian crocodile mummy preserves a fish caught on a bronze hook after more than 2,000 years.

Neuroform Atlas stent-assisted coiling yields favorable outcomes in treatment of intracranial aneurysms in arteries ...

Governor Lucky Aiyedatiwa of Ondo State has approved the yearly payment of the Medical Residency Training Fund (MRTF) to all ...

Iowans are more likely to develop lung cancer than the average American. Demographics and even geology play a role, but ...

As of Friday, January 09, Pulmonx Corporation’s LUNG share price has dipped by 5.24%, which has investors questioning if this ...

Lumexa Imaging (LMRI) rated Buy: resilient outpatient imaging demand, hospital JV moat, and scale-driven FCF growth.

Alternative anodes such as Li₄Ti₅O₁₂ offer improved safety, but their low theoretical capacity severely constrains energy ...

Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...

With more recent focus on STEM education and the rising popularity of artificial intelligence, or AI, companies like Micron ...